Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on March 11, 2004

Stroke. 2004
Published online before print March 11, 2004, doi: 10.1161/01.STR.0000121647.01941.ba
A more recent version of this article appeared on April 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/4/975    most recent
01.STR.0000121647.01941.bav1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saita, K.
Right arrow Articles by Howells, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saita, K.
Right arrow Articles by Howells, D. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Animal models of human disease
Right arrow Imaging
Right arrow Ischemic biology - basic studies
Right arrow Acute Cerebral Infarction
Right arrow PET and SPECT

Submitted on October 8, 2003
Revised on December 10, 2003
Accepted on January 8, 2004

Imaging the Ischemic Penumbra with 18F-Fluoromisonidazole in a Rat Model of Ischemic Stroke

Kazuko Saita MD, PhD; Michelle Chen BSc (Hon); Neil J. Spratt FRACP, B.Med.Sci; Michelle J. Porritt PhD; Gabriel T. Liberatore PhD; Stephen J. Read PhD, FRACP; Christopher R. Levi MBBS, FRACP; Geoffrey A. Donnan MD, FRACP; Uwe Ackermann PhD; Henri J. Tochon-Danguy PhD; John I. Sachinidis PhD; and David W. Howells PhD*

From the Department of Medicine, University of Melbourne (K.S., M.C., G.T.L., N.J.S., G.A.D., D.W.H.), National Stroke Research Institute (N.J.S., G.A.D., D.W.H.), and Centre for Positron Emission Tomography (U.A., H.J.T.-D., J.I.S.), Austin Health, Melbourne, Victoria, Australia; Department of Neurology, John Hunter Hospital (C.R.L.) Newcastle, New South Wales, Australia; Stroke Unit, Royal Brisbane Hospital (S.J.R.), Queensland, Australia.

* To whom correspondence should be addressed. E-mail: david.howells{at}unimelb.edu.au.

Background and Purpose--The ischemic penumbra is a major focus of stroke research. 18F-fluoromisonidazole (18F-FMISO), a positron emission tomography (PET) marker of hypoxic cells, has shown promise as a technique to image the penumbra in humans. Our aim was to delineate the pattern of 18F-FMISO binding in a rat middle cerebral artery transient thread-occlusion model, and correlate this with tissue outcome at 24 hours. We hypothesized that the pattern of 18F-FMISO binding would mimic that seen in humans.

Methods--Thirty-eight rats underwent 2 hours transient middle cerebral artery (MCA) occlusion, and then received 18F-FMISO at time points from 0.5 to 22 hours post-MCA occlusion and were killed 2 hours later. Autoradiographic assessment of 18F-FMISO binding and assessment (triphenyltetrazolium chloride) of the area of infarction were performed on tissue slices.

Results--Until 1 hour after MCA occlusion, 18F-FMISO binding was increased in the entire MCA territory, with little or no infarction visible. Over the next 5 hours, the pattern of binding evolved to a small rim of intensely binding tissue surrounding the infarct core, which itself showed reduced binding compared with the contralateral hemisphere. By 24 hours, there was minimal accumulation of 18F-FMISO binding and a large area of infarction.

Conclusions--The pattern of 18F-FMISO binding rats reproduced the pattern seen in humans, consistent with this tracer being a marker of the ischemic penumbra in both species. This technique may have application in studying the ischemic penumbra in animal models, and correlating this with similar studies in humans.


Key words: stroke • imaging • animal models of human disease • nitroimidazoles • autoradiography




This article has been cited by other articles:


Home page
StrokeHome page
W. Cai, R. Guzman, A. R. Hsu, H. Wang, K. Chen, G. Sun, A. Gera, R. Choi, T. Bliss, L. He, et al.
Positron Emission Tomography Imaging of Poststroke Angiogenesis
Stroke, January 1, 2009; 40(1): 270 - 277.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Takasawa, R. R. Moustafa, and J.-C. Baron
Applications of Nitroimidazole In Vivo Hypoxia Imaging in Ischemic Stroke
Stroke, May 1, 2008; 39(5): 1629 - 1637.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
N. J. Spratt, U. Ackerman, H. J. Tochon-Danguy, G. A. Donnan, and D. W. Howells
Characterization of Fluoromisonidazole Binding in Stroke
Stroke, July 1, 2006; 37(7): 1862 - 1867.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. L. Saver
Time Is Brain--Quantified
Stroke, January 1, 2006; 37(1): 263 - 266.
[Abstract] [Full Text] [PDF]